Comprehensive analysis of China's laboratory equipment market in 2025, valued at over ¥150 billion ($21 billion) and growing at 8-10% annually. Driven by massive R&D investment in pharmaceuticals, biotechnology, environmental monitoring, and semiconductor manufacturing. Covers leading manufacturers including Shanghai Chun Specs (川仪), Beijing Beifen-Ruili (北分瑞利), and Zhejiang Fuli (福立仪器) across segments: analytical instruments (HPLC, GC, mass spectrometry), life science equipment (centrifuges, biosafety cabinets, incubators), and clinical diagnostics. Key trends include domestic substitution as China reduces reliance on imported lab instruments, integration of AI for automated analysis, and smart lab management systems. Examines export growth to Belt and Road countries, government procurement policies favoring domestic equipment, and the emergence of Chinese brands competing with Agilent, Thermo Fisher, and Shimadzu in global markets.
read more..